N
Nikolaos Garmpis
Researcher at National and Kapodistrian University of Athens
Publications - 124
Citations - 1223
Nikolaos Garmpis is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 13, co-authored 100 publications receiving 614 citations.
Papers
More filters
Journal ArticleDOI
From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
Dimitrios Dimitroulis,Christos Damaskos,Serena Valsami,Spyridon Davakis,Nikolaos Garmpis,Eleftherios Spartalis,Antonios Athanasiou,Demetrios Moris,Stratigoula Sakellariou,Stylianos Kykalos,Gerasimos Tsourouflis,Anna Garmpi,Ioanna Delladetsima,Konstantinos Kontzoglou,Gregory Kouraklis +14 more
TL;DR: The current evidence on epidemiology, symptomatology, diagnosis and treatment of hepatocellular carcinoma is described, which remains a challenge to early diagnose, and treat effectively.
Journal ArticleDOI
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review.
Emmanuel N Kontomanolis,Antonios Koutras,Athanasios Syllaios,Dimitrios Schizas,Aikaterini Mastoraki,Nikolaos Garmpis,Michail Diakosavvas,Kyveli Angelou,Georgios Tsatsaris,Athanasios Pagkalos,Thomas Ntounis,Zacharias Fasoulakis +11 more
TL;DR: The evidence that neoplasm develop as the after-effect of the increase of acquired and physical genetic variations in proto-oncogenes and tumor-suppressor genes is highlighted; these form a target group in the cells of neoplasms.
Journal ArticleDOI
Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises
Nikolaos Garmpis,Christos Damaskos,Anna Garmpi,Emmanouil Kalampokas,Theodoros Kalampokas,Eleftherios Spartalis,A. Daskalopoulou,Serena Valsami,Michael C. Kontos,Afroditi Nonni,Konstantinos Kontzoglou,Despina Perrea,Nikolaos Nikiteas,Dimitrios Dimitroulis +13 more
TL;DR: More studies concerning HDAC inhibitors in breast carcinomas along with a more accurate understanding of the TNBC's pathobiology are required for the possible identification of new therapeutic strategies.
Journal ArticleDOI
Triple-Negative Breast Cancer: The Progress of Targeted Therapies and Future Tendencies.
Christos Damaskos,Anna Garmpi,Konstantinos Nikolettos,Michail Vavourakis,Evangelos Diamantis,Alexandros Patsouras,Paraskevi Farmaki,Afroditi Nonni,Dimitrios Dimitroulis,Dimitrios Mantas,Efstathios Antoniou,Nikos Nikolettos,Konstantinos Kontzoglou,Nikolaos Garmpis +13 more
TL;DR: Clinical studies published within the last five years are presented in order to reveal possible targeted therapies against triple-negative breast cancer and the PI3K/AKT/mTOR pathway seems to be a promising field for the development of new anti-TNBC targeted therapies.
Journal ArticleDOI
Solid Pseudopapillary Tumor of the Pancreas: A Single-center Experience and Review of the Literature.
Efstathios Antoniou,Christos Damaskos,Nikolaos Garmpis,Christos Salakos,Giorgos-Antonios Margonis,Konstantinos Kontzoglou,Stefanos Lahanis,Eleftherios Spartalis,Dimitrios Patsouras,Stylianos Kykalos,Anna Garmpi,Nikolaos Andreatos,Timothy M. Pawlik,Gregory Kouraklis +13 more
TL;DR: The overall prognosis of SPT of the pancreas is excellent due to its favorable biological features, even in the presence of distal metastasis.